P2.03-023 Characteristics of NSCLC Patients Treated in First Line Treatment with Tyrosine Kinase Inhibitors (TKI) - Real Data from the Czech Republic
- Resource Type
- Abstract
- Authors
- Skrickova, J.; Chloupkova, R.; Bortlicek, Z.; Pesek, M.; Kolek, V.; Hejduk, K.; Koubkova, L.; Cernovska, M.; Krejci, J.; Zemanová, M.; Havel, L.; Roubec, J.; Hrnciarik, M.; Salajka, F.; Coupkova, H.; Satankova, M.; Benejova, A.; Grygarkova, I.; Opalka, P.; Sixtova, D.
- Source
- In Journal of Thoracic Oncology November 2017 12(11) Supplement 2:S2136-S2136
- Subject
- Language
- ISSN
- 1556-0864